This inventor holds 34 USPTO granted patents and 1 EPO patent, primarily in Enzyme Inhibitors. Top assignees: Burroughs Wellcome Co., Glaxo Wellcome Inc., Alizyme Therapeutics Limited. Active years: 1976-2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- London, EN (1976)
- Hayes, EN (1976 - 1978)
- Hayes, GB (1978 - 1979)
- Beckenham, Kent, GB (1984)
- Kent, GB (1999)
- Beckenham, GB (1986 - 2014)
Company Filing History:
15 out of 521 
6 out of 281 
4 out of 7 
Years Active: 1976-2014
Areas of Expertise:
Title: Harold Francis Hodson – Innovator in Pharmaceutical Chemistry
Introduction
Harold Francis Hodson is a notable inventor based in Beckenham, GB, recognized for his significant contributions to the field of pharmaceutical chemistry. With an impressive portfolio of 32 patents, he has focused on developing innovative solutions for health-related challenges, particularly in the treatment of obesity.
Latest Patents
Hodson's latest inventions include novel 2-oxy-benzoxazinone derivatives aimed at treating obesity. These compounds, characterized by their unique formula (I), are designed to inhibit specific enzymes that catalyze the hydrolysis of ester functionalities. The applications of these compounds extend beyond mere inhibition; they hold promise for medical treatments against obesity and related conditions. Furthermore, his inventions encompass processes for synthesizing these compounds and formulating pharmaceutical compositions that incorporate them. In formula (I), 'A' represents a 6-membered aromatic or heteroaromatic ring, while 'R' denotes a versatile range of organic groups, enhancing the efficacy and utility of the derivatives.
Career Highlights
Throughout his career, Hodson has made significant strides in pharmaceutical development, holding key positions in respected companies such as Burroughs Wellcome Co. and Glaxo Wellcome Inc. His work in these organizations has allowed him to leverage advanced scientific research towards practical applications in medicine, particularly in obesity management.
Collaborations
Hodson's journey is marked by fruitful collaborations with prominent figures in the industry, including his colleagues John Frederick Batchelor and Richard Michael John Palmer. These partnerships have not only fostered innovation but have also contributed to the successful realization of his patents.
Conclusion
Harold Francis Hodson's unwavering commitment to innovation in pharmaceutical chemistry has resulted in numerous patents that potentially transform the landscape of treatments for obesity. His work continues to inspire new approaches and solutions, reflecting the importance of collaboration and research in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile